Utility of Progression Independent of Relapse Activity as a Trial Outcome in Relapsing-Remitting Multiple Sclerosis.

Saved in:
Bibliographic Details
Title: Utility of Progression Independent of Relapse Activity as a Trial Outcome in Relapsing-Remitting Multiple Sclerosis.
Authors: Strijbis EMM; Department of Neurology, MS Center Amsterdam, Amsterdam University Medical Centers, the Netherlands., Mostert J; Department of Neurology, Rijnstate Hospital, Arnhem, the Netherlands., Comtois J; Department of Medicine, Neurology Service, Hôpital de la Cité-de-la-Santé, Laval, QC, Canada., Salter A; Department of Neurology, University of Texas Southwestern Medical Center, Dallas., Repovic P; Multiple Sclerosis Center, Swedish Neuroscience Institute, Seattle, WA., Bowen JD; Multiple Sclerosis Center, Swedish Neuroscience Institute, Seattle, WA., Uitdehaag BMJ; Department of Neurology, MS Center Amsterdam, Amsterdam University Medical Centers, the Netherlands., Cutter GR; Department of Biostatistics, University of Alabama at Birmingham; and., Koch MW; Department of Clinical Neurosciences, University of Calgary, Alberta, Canada.
Source: Neurology [Neurology] 2025 Jan 28; Vol. 104 (2), pp. e210153. Date of Electronic Publication: 2024 Dec 30.
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1526-632X (Electronic) Linking ISSN: 00283878 NLM ISO Abbreviation: Neurology Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1526-632X
DOI:10.1212/WNL.0000000000210153